Biocon Q3 net up 9% at Rs. 93 cr

Subscribe to GoodReturns
For Quick Alerts
For Daily Alerts
    Biocon Q3 net up 9% at Rs. 93 cr
    Biocon: Quotes, News
    BSE 646.35BSE Quote5.85 (0.91%)
    NSE 647.95NSE Quote6.6 (1.02%)
    Biotechnology major Biocon on Friday posted a 9.38% increase in its consolidated net profit at Rs. 92.81 crore for the third quarter ended December 31, 2012.

    The company had posted a net profit of Rs. 84.85 crore during the same period of previous fiscal. Net sales of the company rose to Rs. 634.22 crore for the third quarter, as against Rs. 516.59 crore during the same period of 2011-12 fiscal.

    "We have performed well across all our business verticals. We continue to gain market share for biosimilar insulins in ROW (rest of the world) markets which now accounts for a significant part of our business," Biocon chairman and managing director Kiran Mazumdar-Shaw said in a statement.

    Shares of Biocon were trading at Rs. 266 on the BSE in the afternoon trade, up 0.89% from its previous close.


    Read more about: biocon
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more